2014
18F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors
Luo G, Liu Z, Guo M, Jin K, Xiao Z, Liu L, Xu J, Zhang B, Liu C, Huang D, Hu S, Ni Q, Long J, Yu X. 18F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors. International Journal Of Oncology 2014, 45: 1531-1536. PMID: 25096059, DOI: 10.3892/ijo.2014.2570.Peer-Reviewed Original ResearchConceptsNon-functioning pancreatic neuroendocrine tumorsPancreatic neuroendocrine tumorsPET/CTNeuroendocrine tumorsNon-functioning endocrine pancreatic tumorsPET/CT scansDistant metastatic lesionsShanghai Cancer CenterEndocrine pancreatic tumorsClinical characteristicsMetastatic lesionsTumor sizeCancer CenterTNM stagePancreatic tumorsLarge cohortCT scanClinical valueAdvanced stageSignificant associationTumorsPatientsCTCohortLesionsMetabolic tumour burden assessed by 18F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection
Xu H, Chen T, Wang W, Wu C, Liu C, Long J, Xu J, Zhang Y, Chen R, Liu L, Yu X. Metabolic tumour burden assessed by 18F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection. European Journal Of Nuclear Medicine And Molecular Imaging 2014, 41: 1093-1102. PMID: 24522797, DOI: 10.1007/s00259-014-2688-8.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAntigens, Tumor-Associated, CarbohydrateCarcinoma, Pancreatic DuctalFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedMultimodal ImagingPancreatic NeoplasmsPositron-Emission TomographyPostoperative PeriodRadiopharmaceuticalsTomography, X-Ray ComputedTreatment OutcomeTumor BurdenConceptsSerum CA19-9 levelsRecurrence-free survivalMetabolic tumor volumeCA19-9 levelsMetabolic tumor burdenPancreatic ductal adenocarcinomaResectable pancreatic ductal adenocarcinomaTumor burdenOverall survivalTumor sizePancreatic ductal adenocarcinoma patientsSerum CA19-9Predicting overall survivalPancreatic cancer outcomesOperating characteristic analysisPredictive of outcomePET/CT examinationRadical pancreatectomyTumor volumeCA19-9Predicting OSSurrogate markerDuctal adenocarcinomaTLGMultivariate analysisCapture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip
Sheng W, Ogunwobi O, Chen T, Zhang J, George T, Liu C, Fan Z. Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip. Lab On A Chip 2014, 14: 89-98. PMID: 24220648, PMCID: PMC3918168, DOI: 10.1039/c3lc51017d.Peer-Reviewed Original ResearchMeSH KeywordsAntibodies, ImmobilizedAntigens, NeoplasmAntineoplastic AgentsCell Adhesion MoleculesCell Line, TumorCell SeparationCell SurvivalEpithelial Cell Adhesion MoleculeHumansLeukocyte Common AntigensMaleMicrofluidic Analytical TechniquesNeoplastic Cells, CirculatingPancreatic NeoplasmsTomography, X-Ray ComputedConceptsHigh-performance microchipsMicromixer structurePresented technologyReal-time monitoringChannel geometryFlow rateTransverse flowCapture efficiencyChipDevicesCell capturePersonalized therapeutic treatmentsTumor cell captureAntibody-coated surfaceGreat promiseSpiked tumor cellsIsolation of CTCsWide rangeCancer patients' blood
2009
Duplicate gallbladder arising from the left hepatic duct: Report of a case
Kim R, Zendejas I, Velopulos C, Fujita S, Magliocca J, Kayler L, Liu C, Hemming A. Duplicate gallbladder arising from the left hepatic duct: Report of a case. Surgery Today 2009, 39: 536-539. PMID: 19468813, DOI: 10.1007/s00595-008-3878-4.Peer-Reviewed Original Research
2006
Combined hepatic resection and radiofrequency ablation for multiple hepatic adenomas
Fujita S, Kushihata F, Herrmann G, Mergo P, Liu C, Nelson D, Fujikawa T, Hemming A. Combined hepatic resection and radiofrequency ablation for multiple hepatic adenomas. Journal Of Gastroenterology And Hepatology 2006, 21: 1351-1354. PMID: 16872326, DOI: 10.1111/j.1440-1746.2006.03184.x.Peer-Reviewed Original ResearchMeSH KeywordsAdenomaAdultCatheter AblationElectrocoagulationFemaleHepatectomyHumansLiver NeoplasmsTomography, X-Ray ComputedTreatment Outcome